Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | HK1 | P19367 | 2/20 | 0.39 |
| ▸ | HK2 | P52789 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 7/20 | 0.39 |
| ▸ | CA2 | P00918 | 7/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8651024 | 0.92 | HK1 (0.42) | PTPN1PTPN2HK1HK2CA1 | |
| SCHEMBL7768969 | 0.78 | LGALS8 (0.51) | CA1CA2CA9KDM4EMAPT | |
| SCHEMBL7767611 | 0.77 | SSTR5 (0.43) | CA1CA2CA9TSHRALDH1A1 | |
| SCHEMBL9010587 | 0.76 | ITGB3 (0.37) | KDM4EMAPT | |
| SCHEMBL9010593 | 0.75 | MAG (0.39) | KDM4EALDH1A1MAPT | |
| SCHEMBL7768519 | 0.74 | MAG (0.39) | KDM4EMAPT | |
| SCHEMBL8537938 | 0.73 | LGALS8 (0.61) | CA1CA2CA9 | |
| SCHEMBL9238485 | 0.73 | LGALS8 (0.61) | CA1CA2CA9 | |
| SCHEMBL8537936 | 0.73 | LGALS8 (0.61) | CA1CA2CA9 | |
| SCHEMBL7155090 | 0.73 | CA1 (0.57) | PTPN1HK1HK2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5767268-A | TREATMENT OF DISORDERS CHARACTERIZED BY EXCESSIVE OR DESTRUCTIVE PROLIFERATION OF SMOOTH MUSCLE CELLS | HOFFMANN-LA ROCHE INC. (US) | 1998-06-16 | — | — | US | disclosed |
| EP-0741139-A1 | Sulphuric acid esters of amino sugars | F. HOFFMANN-LA ROCHE AG (CH) | 1996-11-06 | — | — | EP | disclosed |